Physician Resources
Recently Added |view more
News
International Kidney Cancer Collaboration with Leadership from Philadelphia
Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, ...
News
Our Motto: Professional, Personable, and Proactive
“As the front line of a patient’s journey, our front desk and surgery scheduling teams play a crucial role in shaping each patient’s first impression of the Fox Chase Cancer Center – Temple Health brand within our urology outpatient clinics. ...
News
Connecting Across Continents: From Philadelphia to Kigali
When Samuel Ivan, MD chose a Reconstructive and Prosthetic Urology Fellowship at Fox Chase, his goal was to train with Fellowship Director Jay Simhan MD, FACS, Chair of the Department of Urology at Temple University Hospital and the Lewis ...
News
The foundation of every cancer diagnosis starts behind the scenes, where a pathologist and a team of specialists painstakingly evaluate a patient’s molecular, cytogenetic, and flow cytometry testing to determine whether the individual ...
News
Fox Chase Radiation Oncology Strikes Gold with ASTRO 2025 Research
Moving sophisticated clinical ideas into the mainstream is a Fox Chase hallmark. Nowhere was that more evident than at this year’s ASTRO, in the city of the Golden Gate Bridge, where research from Fox Chase radiation oncology residents ...
News
Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase ...
News
Jennifer Kelly, BSN, RN, CURN, a nurse with the Fox Chase-Temple Urologic Institute, has become the first nurse in the Temple Health system to earn certification from the Society of Urologic Nurses & Associates (SUNA).
News
Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness
Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with esophageal cancer and non-small cell lung cancer.